Paul G. Ambrose
Clinical AdvisorDr. Paul G. Ambrose, Ph.D., M.D., serves as the President of the Institute for Clinical Pharmacodynamics (ICPD), Latham, New York. Dr. Ambrose is an expert in anti-infective translational science, with the goal of improving patient care through the application of pharmacokinetic-pharmacodynamic (PK-PD) principles. Dr. Ambrose serves as Director of the Institute for Clinical Pharmacodynamics (ICPD) at Ordway Research institute in Albany, NY. Dr. Ambrose is Clinical Advisor of Spero Therapeutics, Inc. He was Scientific Advisors for Spero Therapeutics, LLC since May 2014. He has been a Member of Scientific and Clinical Advisory Board at Entasis Therapeutics since December 15, 2015. He serves as Member of Scientific & Clinical Board at Entasis Therapeutics Holdings Inc. He has been Member of Scientific Advisory Board at Zavante Therapeutics, Inc. since August 31, 2016. He serves as a Member of Scientific Advisory Board at Cempra, Inc. He is also an Honorary Research Fellow in Infectious Diseases at the University of Oxford, Oxford, UK and Adjunct Associate Research Professor at the University at Buffalo, Buffalo, New York. Dr. Ambrose served as an Editor for four textbooks, most notably the first and second editions of Antimocrobial Pharmacodynamics in Theory and Clinical Practice. He is an Editor of Antimicrobial Agents and Chemotherapy. He is the author of over 90 peer-reviewed scientific publications and approximately 100 scientific abstracts. Dr. Ambrose received his Pharm.D. from the University of the Pacific and completed a Post-Doctoral Fellowship in infectious diseases at Hartford Hospital.
Positions
- Company NameSpero Therapeutics, Inc.Stock CodeSPROPositionClinical AdvisorColleagues
- EPEsther P. RajaveluCEO, President, CFO, Chief Business Officer, Treasurer & Director
- FEFrank Edward ThomasIndependent Chairman
- TKTimothy KeutzerChief Operating Officer
- JRJohn RaymondSenior Vice President of Finance & Business Operations
- DJDebra Jeske ZackChief Medical Officer
- ADAmy Dix RockChief Regulatory & Quality Officer
- CSCynthia SmithIndependent Director
- GLGordon L. ArcherClinical Advisor
